FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
DMARDs not linked to Alzheimer’s risk for seniors with RA
Apr 12, 2022
No reduction in the risk for Alzheimer’s disease and related dementia was seen with treatment with tofacitinib, tocilizumab or tumor necrosis factor inhibitors versus abatacept.
DMARD prescribing low for older adults with rheumatoid arthritis
Apr 11, 2022
Any DMARD use was recorded at 56% of rheumatologist visits and 30% of primary care provider visits.
Medical marijuana may not aid pain, anxiety, depression symptoms
Mar 25, 2022
But many obtaining immediate access to a medical marijuana card developed cannabis use disorder.
Fitbit recalls more than 1 million iconic smartwatches due to burn hazard
Mar 03, 2022
The lithium-ion battery in the Ionic smartwatch can overheat and cause burns.
USPSTF updates guidance on statins for primary prevention of cardiovascular disease
Feb 22, 2022
The evidence currently is insufficient for assessing the balance of benefits and harms of statin initiation for primary prevention of CVD and mortality in adults aged 76 years or older.
Smartphone system can assess blood clotting from single drop
Feb 14, 2022
The micro-mechanical system using a vibration motor and camera on smartphones can compute the PT/INR.
Aqueous biomarkers may help predict treatment response in neovascular age-related macular degeneration
Feb 01, 2022
Treated patients who required less frequent anti-VEGF injections had increased apolipoprotein B100.
USPSTF: Individualize counseling for primary prevention of cardiovascular disease
Jan 18, 2022
For adults without known CVD risk factors, individualize the decision to refer to behavioral counseling to promote healthy diet and physical activity.
Pfizer says omicron-specific vaccine ready by March
Jan 12, 2022
Pfizer also is working to improve its current COVID-19 vaccine “to address any future variant of potential concern, if needed.”